Butler Hospital, Rhode Island Mood & Memory Research Institute join Alzheimer’s drug study

PROVIDENCE — Butler Hospital’s Memory and Aging Program and the Rhode Island Mood & Memory Research Institute are participating in Novartis Pharmaceuticals’ international Alzheimer’s disease prevention study of the efficacy of an oral medication, CNP520, in slowing the buildup of amyloid plaques and delaying cognitive decline in people at risk for the disease. Amyloid build-up is one…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -